Arthur Daemmrich is the director of the Lemelson Center for the Study of Invention and Innovation at the Smithsonian Institution. His research explores relationships between regulation and innovation, with a focus on historical and comparative studies of the pharmaceutical industry, chemicals sector, and healthcare systems.